Safest Second Antihypertensive Medication for Patients with History of Stroke and Pulmonary Embolism

Rationale for ARB Selection

ARBs have a favorable safety profile with minimal risk of cough and do not increase risk of bronchospasm, which is particularly important in patients with pulmonary conditions, as noted by the European Heart Journal 1, 2

The World Stroke Organization recommends ACE inhibitors combined with thiazide diuretics for patients with history of stroke, with a target blood pressure of <130/80 mmHg 3, 4
If the patient is on a different first-line agent, an ARB would be preferred over an ACE inhibitor due to better tolerability, as reported by the European Heart Journal 1, 2

Calcium channel blockers, such as dihydropyridines like amlodipine, may be considered as they don't adversely affect pulmonary circulation, according to the European Heart Journal 1, 2

The target blood pressure for patients with history of stroke should be <130/80 mmHg, as recommended by the World Stroke Organization 3, 4
Blood pressure reduction should be gradual to prevent complications from excessive lowering, especially in patients with history of stroke, as noted by the European Heart Journal 5, 6
Controlled BP reduction is critical as large reductions have been associated with ischemic stroke and death, as reported by the European Heart Journal 5, 7

Labetalol is recommended for acute management of hypertensive emergencies in stroke patients but is not ideal for long-term management in patients with pulmonary embolism history, according to the European Heart Journal 5, 6, 7

Thiazide diuretics at low doses may be appropriate, especially in combination with existing ACE inhibitor therapy, as recommended by the World Stroke Organization 3, 4
If resistant hypertension develops, low-dose spironolactone may be added as a third agent, as noted by the European Heart Journal 1, 2